Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.50+1.54 (+10.29%)
At close: 04:00PM EDT
17.14 +0.64 (+3.88%)
After hours: 05:12PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close14.96
Open15.21
Bid16.50 x 3200
Ask17.16 x 1000
Day's Range15.21 - 16.74
52 Week Range10.41 - 21.19
Volume993,552
Avg. Volume818,317
Market Cap1.104B
Beta (5Y Monthly)0.92
PE Ratio (TTM)N/A
EPS (TTM)-1.99
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for KURA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Kura Oncology, Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    16 hours agoArgus Research
View more
Advertisement
Advertisement